An Estimate of the Variance of Estimators for Lead Time and Screening Benefit in Randomised Cancer Screening Trials

Variance estimators are derived for estimators of the average lead time and leverage benefit time due to screening in a randomized screening trial via influence functions. The influence functions demonstrate that these estimators are asymptotically equivalent to the mean difference, between the study and control case groups, in the survival times. For estimating benefit time, the survival time is measured since time of diagnosis. Asymptotic variances of these estimators can be calculated in a straightforward manner from the influence functions, and these variances can be estimated from actual trial data. The performance of the variance estimates is assessed via a simulated screening trial. The situation involving censored data is also discussed.